Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gaviscon versus omeprazole for untreated gastroesophageal reflux heartburn
2010-019563-11Phase 4Completed
- Sponsor
- Reckitt
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of magnesium trisilicate and omeprazole in gastroesophageal reflux disease (GERD) (2 arms), sponsored by Reckitt. Primary endpoint: Time to obtain 24 consecutive hours of heartburn relief. Started May 2010; status: completed.
02
Drugs
magnesium trisilicateomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on 2010-019563-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019563-11.